Phase II study of ifosfamide, etoposide, and oxaliplatin (IFETOx) chemotherapy for relapsed or refractory non-Hodgkin’s lymphoma

By Kim Seon-Kyeong   Song Moo-Kon   Chung Joo   Shin Ho-Jin  

International Journal of Hematology, Vol. 98, Iss. 5, 2013-11 ,pp. : 543-548

Springer Publishing Company

Access to resources Recommend Favorite

Thalidomide plus chemotherapy exhibit enhanced efficacy in the clinical treatment of T-cell nonHodgkin's lymphoma: A prospective study of 46 cases

By            

Molecular and Clinical Oncology, Vol. 2, Iss. 5, 2014-01 ,pp. : 695-700

Spandidos Publications

Access to resources Recommend Favorite

Relation between S-phase fraction of myeloma cells and anemia in patients with multiple myeloma - a randomized multicenter study. The European study group of erythropoietin (Epoetin Beta) treatment in multiple myeloma and non-Hodgkin's lymphoma

By Fossa A.   Brandhorst D.   Myklebust J.H.   Seeber S.   Nowrousian M.R.  

Experimental Hematology, Vol. 27, Iss. 11, 1999-11 ,pp. : 1621-1626

Elsevier

Access to resources Recommend Favorite

Monoclonal antibody therapy with CAMPATH-1H in patients with relapsed high- and low-grade non-Hodgkin's lymphomas: a multicenter phase I/II study

By Uppenkamp M.   Engert A.   Diehl V.   Bunjes D.   Huhn D.   Brittinger G.  

Annals of Hematology, Vol. 81, Iss. 1, 2002-01 ,pp. : 26-32

Springer Publishing Company

Access to resources Recommend Favorite

Immunogenicity of Influenza Vaccination in Patients with Non-Hodgkin Lymphoma

By Centkowski Piotr   Brydak Lidia   MachaŁa Magdalena   Kalinka-Warzocha Ewa   BŁAsiŃSka-Morawiec Maria   Federowicz Irena   Walewski Jan   Wc{E}? Joanna   WoŁOwiec Dariusz   Lech-MaraŃDa Ewa   Sawczuk-Chabin Joanna   BiliŃSki PrzemysŁAw   Warzocha Krzysztof  

Journal of Clinical Immunology, Vol. 27, Iss. 3, 2007-05 ,pp. : 339-346

Springer Publishing Company

Access to resources Recommend Favorite